In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of ORIC Pharmaceuticals Inc (NASDAQ: ORIC) was $9.51 for the day, down -2.56% from the previous closing price of $9.76. In other words, the price has decreased by -$2.56 from its previous closing price. On the day, 0.59 million shares were traded. ORIC stock price reached its highest trading level at $10.03 during the session, while it also had its lowest trading level at $9.35.
Ratios:
Our analysis of ORIC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 10.39 and its Current Ratio is at 10.39. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.03.
On September 22, 2023, Wedbush started tracking the stock assigning a Outperform rating and target price of $8.
H.C. Wainwright Upgraded its Neutral to Buy on March 23, 2023, while the target price for the stock was maintained at $16.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 06 ’24 when Chacko Jacob sold 40,000 shares for $16.21 per share. The transaction valued at 648,380 led to the insider holds 728,544 shares of the business.
Chacko Jacob sold 26,042 shares of ORIC for $320,186 on Feb 07 ’24. The PRESIDENT AND CEO now owns 768,544 shares after completing the transaction at $12.29 per share. On Feb 06 ’24, another insider, Chacko Jacob, who serves as the PRESIDENT AND CEO of the company, sold 13,958 shares for $12.12 each. As a result, the insider received 169,160 and left with 794,586 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORIC now has a Market Capitalization of 640743872 and an Enterprise Value of 442770304.
Stock Price History:
Over the past 52 weeks, ORIC has reached a high of $16.65, while it has fallen to a 52-week low of $4.89. The 50-Day Moving Average of the stock is -24.31%, while the 200-Day Moving Average is calculated to be 3.66%.
Shares Statistics:
ORIC traded an average of 566.08K shares per day over the past three months and 508520 shares per day over the past ten days. A total of 54.87M shares are outstanding, with a floating share count of 40.08M. Insiders hold about 40.52% of the company’s shares, while institutions hold 60.18% stake in the company. Shares short for ORIC as of 1711584000 were 8137869 with a Short Ratio of 14.38, compared to 1709164800 on 6485747. Therefore, it implies a Short% of Shares Outstanding of 8137869 and a Short% of Float of 13.13.
Earnings Estimates
The stock of ORIC Pharmaceuticals Inc (ORIC) is currently in the spotlight, with Ericsson analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $8.14, with high estimates of $9.51 and low estimates of $29.12.
Analysts are recommending an EPS of between $Healthcare and $Financial Services for the fiscal current year, implying an average EPS of $Real Estate.
